How to Apply to Bausch Health

9 min read Last updated April 20, 2026
Blake Crosley
Blake Crosley Researched using publicly available information, hiring data, and ATS analysis.

Key Takeaways

  • Bausch Health and Bausch + Lomb are separate publicly-listed companies on separate ATS instances even though BHC still owns roughly 88 percent of BLCO; apply to the right entity.
  • The ATS is SAP SuccessFactors with the Jobs2Web (j2w) front end, not Workday; clean single-column resumes and fully-completed structured profiles win.
  • The Valeant scandal is not a forbidden topic; it is a litmus test, especially for finance, legal, regulatory, and compliance roles. Engage with it honestly.
  • Debt deleveraging is the strategic context for almost every operating decision; finance, procurement, supply-chain, and IT candidates who can speak to cost-out and cash discipline are advantaged.
  • Xifaxan loss-of-exclusivity preparation is the largest single business risk and shapes Salix hiring; show you understand the franchise and the generic threat.
  • Quebec-based roles require honest French proficiency assessment under Bill 96; do not inflate language claims.
  • The Solta Medical aesthetic-devices business is a real growth franchise distinct from the rest of the portfolio and hires on a faster, more product-centric cadence.

About Bausch Health

Bausch Health Companies Inc. (NYSE: BHC; TSX: BHC) is a Laval, Quebec-headquartered specialty pharmaceutical company that traces its roots to the 1959 founding of ICN Pharmaceuticals and the 1983 founding of Biovail. The current company emerged from the 2010 Biovail/Valeant merger, expanded aggressively through more than one hundred acquisitions under former CEO J. Michael Pearson (most notably the 2015 Salix Pharmaceuticals deal), then collapsed publicly in 2015-2016 when the Philidor specialty pharmacy arrangement, aggressive price increases on legacy drugs, and accounting restatements wiped out roughly ninety percent of the equity value and triggered congressional hearings, an SEC settlement, and the eventual rebrand from Valeant to Bausch Health in July 2018. Joseph Papa was hired in May 2016 to stabilize the business and lead a turnaround focused on simplifying the portfolio, paying down debt, and rebuilding regulatory and reputational trust. Thomas Appio, who ran the international segment, succeeded Papa as CEO in May 2023. Today the company employs roughly twenty-one thousand people across more than one hundred countries and reported approximately $4.6 billion in 2024 revenue. The portfolio is organized into Salix (gastrointestinal, anchored by Xifaxan/rifaximin and Trulance), International (diversified branded and generics), Solta Medical (aesthetic energy-based devices including Thermage, Clear + Brilliant, Fraxel, and VASER), Diversified (dentistry, neurology, and generics), and an ophthalmology segment that overlaps with the still-controlled subsidiary Bausch + Lomb. Bausch + Lomb completed its IPO in May 2022 on the NYSE under ticker BLCO, but Bausch Health retains roughly an 88 percent ownership stake. A full separation has been contemplated and publicly discussed for years and remains an open strategic question that materially affects equity grants, internal mobility between BHC and BLCO, and the long-term identity of the parent. The company carries a debt load that peaked near $26 billion and stood near $20 billion at year-end 2024; deleveraging is the explicit operating priority and shapes nearly every internal capital and headcount decision. The largest single business risk is the patent and authorized-generic exposure on Xifaxan, which has accounted for roughly forty percent of consolidated revenue in recent years and is the subject of ongoing litigation and competitive entry preparation. Commercial U.S. operations sit in Bridgewater, New Jersey; corporate is split between Laval and Bridgewater; major manufacturing and R&D nodes include Steinbach (Manitoba), Laval, Rochester (NY), Tampa (FL), and several international sites.

Application Process

  1. 1
    Search openings on careers

    Search openings on careers.bauschhealth.com (Bausch Health) or careers.bauschlomb.com (Bausch + Lomb). The two are now separate ATS instances even though Bausch Health still owns roughly 88 percent of B+L; pick the entity that owns the role rather than assuming internal mobility between them.

  2. 2
    Create one candidate account per entity

    Create one candidate account per entity. Both run on SAP SuccessFactors with the Jobs2Web (j2w) recruitment marketing front end, so the parser handles plain reverse-chronological PDF or Word resumes well and chokes on multi-column or graphic templates.

  3. 3
    Apply within seven to ten days of posting where possible

    Apply within seven to ten days of posting where possible. Specialty pharma req volume is lumpy and many roles are filled by referral or internal slate before the public posting closes; late applications often go to a passive talent pool.

  4. 4
    Complete the SuccessFactors profile fields, not just the resume upload

    Complete the SuccessFactors profile fields, not just the resume upload. Recruiters filter on the structured fields (most recent employer, degree, license, geography), and a blank profile combined with an attached resume is the most common reason qualified applicants get filtered out automatically.

  5. 5
    Expect a recruiter screen within one to three weeks for active commercial, R&D,

    Expect a recruiter screen within one to three weeks for active commercial, R&D, and IT roles; manufacturing roles in Steinbach, Laval, and Tampa often move faster because of shift coverage urgency.

  6. 6
    Be ready to discuss the legacy Valeant period directly if you are interviewing f

    Be ready to discuss the legacy Valeant period directly if you are interviewing for finance, legal, regulatory, compliance, or investor-facing roles. Interviewers will want to see that you understand what changed after 2016 and why, not that you pretend the history did not happen.

  7. 7
    For Quebec-based roles, expect French-language proficiency expectations to be as

    For Quebec-based roles, expect French-language proficiency expectations to be assessed honestly per Bill 96 even when the working language of the team is English; corporate and R&D roles in Laval frequently require functional French for internal communications and government interactions.

  8. 8
    After offer, background and reference checks are handled through a third-party v

    After offer, background and reference checks are handled through a third-party vendor and typically run seven to fourteen business days; manufacturing and lab roles add a drug screen and, in some U.S. sites, a controlled-substance background check tied to DEA-registered facilities.

Resume Tips for Bausch Health

recommended

Use a single-column, ATS-clean PDF or Word file with standard section headers (E

Use a single-column, ATS-clean PDF or Word file with standard section headers (Experience, Education, Skills, Licenses). The Jobs2Web parser handles this layout reliably and mangles two-column, table-based, or heavily graphic templates.

recommended

Mirror the requisition language for therapeutic area, product franchise, and reg

Mirror the requisition language for therapeutic area, product franchise, and regulatory framework. For Salix roles use 'gastroenterology' and name Xifaxan, Trulance, Relistor, or Apriso explicitly if you have promoted or supported them; for Solta use 'aesthetic energy-based devices' and name Thermage, Fraxel, Clear + Brilliant, or VASER.

recommended

Quantify commercial impact in pharma-native terms: TRx and NRx growth, market sh

Quantify commercial impact in pharma-native terms: TRx and NRx growth, market share point gains, sample-to-script ratios, MSL engagement counts, formulary wins, and managed-care contract pull-through. Vague 'exceeded targets' language is a common silent rejection trigger for sales and marketing roles.

recommended

List specific regulatory and quality frameworks you have worked under: FDA 21 CF

List specific regulatory and quality frameworks you have worked under: FDA 21 CFR Part 11, Part 210/211 cGMP, ICH Q7-Q10, EU Annex 11, Health Canada DEL, ANVISA, PMDA. Manufacturing and quality recruiters search on these strings.

recommended

Surface debt-environment-relevant skills for finance, FP&A, treasury, procuremen

Surface debt-environment-relevant skills for finance, FP&A, treasury, procurement, and supply-chain roles: covenant management, refinancing experience, working-capital optimization, zero-based budgeting, and cost-out program leadership all map directly to the company's operating priorities.

recommended

Include language proficiency with an honest CEFR-style level (for example, Frenc

Include language proficiency with an honest CEFR-style level (for example, French B2 written and spoken) rather than vague labels. Quebec hiring managers verify this in interview and inflated claims are an immediate trust loss.

recommended

For R&D and clinical roles, list trial phases, indication areas, and submission

For R&D and clinical roles, list trial phases, indication areas, and submission types you have supported (IND, NDA, sNDA, MAA, NDS, ANDS) and the regulatory agencies involved, not just job titles.

recommended

Keep the resume to two pages for most roles, three only for senior R&D, regulato

Keep the resume to two pages for most roles, three only for senior R&D, regulatory, or executive positions where publication and submission lists genuinely matter.

ATS System: SAP SuccessFactors with Jobs2Web (j2w) Recruitment Marketing

Both Bausch Health and the separately-listed Bausch + Lomb run SAP SuccessFactors Recruiting on the back end with the Jobs2Web (j2w) recruitment marketing front end on careers.bauschhealth.com and careers.bauschlomb.com respectively. The candidate-facing search and apply pages are served from the j2w platform (visible in script paths) while the application, profile, and recruiter workflow live in SuccessFactors at performancemanager.successfactors.eu. The parser is competent on plain text but unforgiving of layout tricks; the search relevance engine weights structured profile fields heavily, so leaving them blank is more damaging than on a Workday or Greenhouse instance.

  • Submit a plain reverse-chronological PDF or Word document; avoid two-column layouts, text inside tables, headers and footers with contact info, and any graphic that contains text.
  • Fill out every structured field in the SuccessFactors candidate profile, especially current employer, most recent title, degree, geography, work authorization, and any licenses (RPh, PharmD, RN, P.Eng., CPA, Six Sigma).
  • Use the same job titles and keywords on the resume as in the SuccessFactors profile so the internal recruiter view does not flag a mismatch.
  • Save both an EN-CA and EN-US version of your resume if you are applying to both Laval and Bridgewater, and a FR-CA version for Quebec-language roles; the parser handles Latin-1 accented characters but display and tagging are cleaner with locale-matched files.
  • After applying, set up a saved search and email alert in your candidate account for related requisitions; SuccessFactors recruiters frequently invite candidates from the talent pool when a similar req opens in the same job family.
  • If you are an internal employee, apply through the internal SuccessFactors career site and notify your manager in advance per the internal mobility policy, which the company enforces strictly.

Interview Culture

Interviews at Bausch Health are generally structured, multi-round, and slower than at smaller pharma peers; expect a recruiter phone screen, a hiring manager video interview, a panel of two to four functional peers, and a final interview with the function lead or a cross-functional stakeholder. Commercial and medical-affairs roles often add a written or live presentation (a brand plan, a launch readiness assessment, or a scientific platform walk-through). R&D, regulatory, and quality roles routinely include a deep technical interview and a behavioral panel keyed to compliance and quality culture. Expect direct questions about the post-Valeant compliance environment, the company code of conduct, and how you have handled pricing, promotional review, or off-label situations in past roles; vague answers here are a fast disqualifier because the legal and compliance functions still review hires in sensitive roles. Tone varies by site: Bridgewater commercial and Laval corporate interviews trend formal and consensus-driven, Steinbach manufacturing interviews are more direct and operational, and Solta interviews in Bothell and Hayward run faster and more product-centric. Compensation conversations are explicit and recruiter-led; bring a defensible target tied to function and geography rather than to total cash at your current employer. Decisions can take two to six weeks after the final round because of internal req-level approvals tied to the deleveraging plan, so plan your timeline accordingly and keep other processes warm.

What Bausch Health Looks For

  • Specialty-pharma fluency: explicit experience in gastroenterology, aesthetics, ophthalmology, dentistry, or neurology rather than generic large-pharma exposure.
  • Compliance maturity: clean track record on promotional review, OPDP/PAAB submissions, sample accountability, transparency reporting, and Sunshine Act or PCPA disclosures, with the ability to talk through a real-world ambiguous call you made.
  • Cost-and-cash discipline: comfort working in a high-debt, capital-disciplined environment where 'do more with less' is operating reality, not slogan, and where capex and headcount approvals are slow.
  • Regulatory submission and audit experience: named submissions you contributed to (NDA, sNDA, MAA, NDS, 510(k) for Solta devices) and named audits you survived (FDA, Health Canada, EMA, ANVISA, PMDA, ISO 13485 for devices).
  • Bilingual capacity for Quebec roles: functional French for Laval corporate, R&D, and government-facing positions, and the willingness to operate in both languages day to day.
  • Manufacturing technical depth for Steinbach, Laval, Tampa, and Greenville sites: cGMP, deviation and CAPA closure, validation (IQ/OQ/PQ), tech transfer, and aseptic processing where applicable.
  • Comfort with public-company scrutiny: every email, deck, and decision lives under SOX and securities-disclosure rules, and the company has zero appetite for repeat reputational risk after the 2015-2016 events.
  • Cultural pattern-recognition: ability to thrive in a still-restructuring organization where reporting lines, segment definitions, and the B+L separation question continue to shift.

Frequently Asked Questions

Is Bausch Health the same company as Valeant Pharmaceuticals?
Yes. Bausch Health is the renamed Valeant Pharmaceuticals International. The company adopted the Bausch Health name in July 2018 to signal a turnaround from the 2015-2016 Philidor specialty-pharmacy controversy, accounting restatements, and price-increase scandals. The legal entity, ticker history, debt stack, and many of the legacy assets are continuous; the rebrand was real strategic repositioning, not a corporate reorganization.
Is Bausch + Lomb a separate company now?
Bausch + Lomb completed its IPO on the NYSE under ticker BLCO in May 2022 and operates with its own board, financial statements, and ATS at careers.bauschlomb.com. However, Bausch Health still owns approximately 88 percent of Bausch + Lomb as of late 2024. A full separation has been publicly discussed for years and is contemplated but not consummated; the open question affects equity grants and internal mobility between the two entities.
What ATS does Bausch Health use and how should I tailor my resume?
Both Bausch Health and Bausch + Lomb run SAP SuccessFactors Recruiting with the Jobs2Web (j2w) front end. Submit a single-column reverse-chronological PDF or Word resume with plain section headers, mirror the requisition keywords for therapeutic area and franchise, and fully complete the structured profile fields in the candidate account. Two-column or graphic resumes parse poorly, and blank profile fields are weighted as missing data by the recruiter view.
Should I bring up the Valeant scandal in interviews?
If you are interviewing for finance, legal, regulatory, compliance, communications, or investor-relations roles, expect interviewers to raise it themselves and prepare a thoughtful answer. Show you understand what happened (Philidor, price increases, restatements), what changed after 2016 (governance, compliance program, leadership turnover, rebrand), and why those changes matter to the role you are interviewing for. Pretending the history does not exist signals naivete; engaging with it directly signals fit.
Is the company financially stable given the debt load?
Bausch Health carries roughly $20 billion in debt at year-end 2024, down from a peak near $26 billion. Deleveraging is the explicit operating priority and the company services its debt and operates profitably, but headcount, capex, and discretionary spend are tightly controlled and refinancing windows shape strategic timing. Treat 'high-debt operating environment' as a permanent context for the role rather than a temporary phase.
What is the largest business risk that affects hiring?
Loss of exclusivity on Xifaxan (rifaximin), which has historically contributed roughly forty percent of consolidated revenue. Litigation and authorized-generic preparation are ongoing. Salix-franchise hiring, U.S. commercial restructuring, and capital allocation are all influenced by Xifaxan-related scenario planning, and candidates who understand this context interview better than those who treat the franchise as a perpetual cash machine.
Do I need to speak French to work at the Laval headquarters?
Functional French is expected for most corporate, R&D, and government-facing roles in Laval under Quebec's Bill 96 framework, even when the working language of a specific team is English. Manufacturing roles at the Laval site similarly expect bilingual capability for floor communication and documentation. Be honest about your level using a CEFR-style descriptor (for example, B2 written and spoken); inflated claims are verified in interview.
What does the interview process look like end to end?
Most professional roles run a recruiter screen, a hiring manager video interview, a two-to-four-person functional panel, and a final round with the function lead or a cross-functional stakeholder. Commercial and medical-affairs roles often add a written or live presentation. Total elapsed time is typically four to eight weeks; manufacturing roles in Steinbach, Laval, and Tampa move faster. Decisions after the final round can take two to six weeks because of req-level approval routing tied to the deleveraging plan.
What is Solta Medical and is it a separate hiring track?
Solta Medical is the aesthetic energy-based devices business within Bausch Health, with brands including Thermage, Fraxel, Clear + Brilliant, and VASER. It is a real growth franchise inside an otherwise debt-managed pharma portfolio, hires on a faster and more product-centric cadence, and concentrates roles in Bothell, Hayward, and field-sales territories serving dermatology and plastic-surgery practices. Apply through the same Bausch Health ATS but expect a noticeably different interview tone than for Salix or international roles.
Are there unions at Bausch Health and how does that affect hiring?
Yes. Quebec manufacturing operations have organized labor representation typical of Canadian pharmaceutical manufacturing, and the company negotiates collective agreements that govern shift, wage, and seniority structures at affected sites. For union-covered roles, hiring is governed by the collective agreement and posting rules; for non-union professional and management roles at the same sites, the standard Bausch Health hiring process applies. If you are interviewing for a site leadership role, expect questions about labor-relations experience.
Check Your Resume Before Applying → View open positions at Bausch Health

Related Resources

Similar Companies

Sources

  1. Bausch Health Companies Inc. - Annual Report and Investor Relations —
  2. Bausch Health Careers (SAP SuccessFactors / Jobs2Web ATS) —
  3. Bausch + Lomb Careers (separate ATS instance post-IPO) —
  4. Bausch + Lomb 2022 IPO Form S-1 (SEC EDGAR) —
  5. Valeant SEC Settlement and Restatement History (SEC press releases) —
  6. Bausch Health Q4 2024 Earnings and Debt Position —
  7. Salix Pharmaceuticals Brand Portfolio (Xifaxan, Trulance, Relistor) —
  8. Solta Medical Brand Portfolio (Thermage, Fraxel, Clear + Brilliant) —
  9. Quebec Bill 96 - An Act Respecting French, the Official and Common Language of Quebec —
  10. Glassdoor - Bausch Health Companies Reviews —